
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Paxlovid (PF-07321332/ritonavir) does not have a Marketing Authorization. It has been granted an Emergency Use Authorization (EUA) by the Tunisia Ministry of Health for the treatment of COVID-19 in adults who do not require supplemental oxygen and who are at increased risk for progression to severe COVID-19.
PAXLOVID (nirmatrelvir/ritonavir)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
PAXLOVID Quick Finder
Submit a medical question for Pfizer prescription products.
To report an adverse (event) reaction with Pfizer product, please contact Pfizer pharmacovigilance at [email protected].